Empire Genomics
Leader in the field of molecular diagnostic services for oncology diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD11—17m (Dealroom.co estimates May 2016.)
Town of Lancaster New York (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$142k | Grant | ||
$1.0m | Series A | ||
$1.8m | Series B | ||
| N/A | $500k | Debt | |
* | N/A | Acquisition | |
| Total Funding | AUD4.5m | ||
Related Content
Recent News about Empire Genomics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.